Kara OBrien

Company: Novartis AG

Job title: ED Precision Diagnostics

Seminars:

Panel Discussion: Establishing Partnerships to Develop, Commercialize, & Decentralize Companion Diagnostics for Unprecedented Global Impact 11:35 am

When should partnerships be optimized to leverage approval of and access to biomarker information? Maximizing market access through strategic partnerships with key stakeholders Understanding the value of consistent decentralized testing in the management of clinical trialsRead more

day: Day 3 Track C

Bridging the Gap for Clinical Biomarkers Between Oncology & Non-Oncology Therapeutic Areas to Expedite Personalized Treatment 4:40 pm

What insights can be leveraged from the extensive experience with precision approaches in oncology as biopharmaceutical companies explore new therapeutic domains? How have recent advancements in genomic sequencing and bioinformatics contributed to new discoveries in diverse therapeutic areas? Unlocking the limitless potential of CDx in new areas: an evaluation of the promise of precision medicineRead more

day: Day One